Waters Corporation

WAT · Healthcare · · USD

409.38 USD

0.00 (-1.01%)

● Updated 2026-09-07 20:34 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Short-term (Swing)

/ 100

Technical 75

Trend & RS 74

Momentum 78

Fundamental (0%) 89

Macro 64

Liquidity 39

Component	Score	Weight
Technical	75.0	40%
Trend & RS	74.5	20%
Momentum	77.8	20%
Fundamental	88.9	0%
Macro	64.4	15%
Liquidity	38.8	5%

Trade Setup

Entry	409.38
Stop Loss	384.54 (6.1%)
Target 1 (1:1)	434.22 (+6.1%)
Target 2 (2:1)	459.06 (+12.1%)

ATR(14)	12.42 (3.0%)
Risk per Share	24.84
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	25.8	-0.97
Momentum	77.8	+1.11
Quality	30.0	-0.80
Composite	44.5

Quality Scores

Piotroski F-Score 7 /9 — Strong

✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 9.21 — Safe Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Fair Value

Metric	Stock	Sector	vs Peers
P/E Ratio	104.2	22.0	+374% above
P/B Ratio	2.6	4.0	Below

Comparing against Healthcare median multiples.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

122.49

Market Price

409.38

Upside

-70.1%

Margin of Safety	-234.2%
Stage 1 PV (5yr FCF)	2,371,736,043
Terminal Value PV	9,655,161,616
Total Enterprise Value	12,026,897,659

Assumptions

Base FCF	308,696,328
Growth Rate (5yr)	25.0%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

46.99%

Full Kelly

23.5%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 72/100. Estimated win rate 62%, avg win 9.3%, avg loss 3.6%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

53.59

RSI(14)

5.9342

MACD

Relative Strength (RS) WEAK RS

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	↑ RISING (+7.3% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	No (6d since high)
Sector Outperformance	+4.3% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

WEAK RS: Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.

Technical Indicators

Indicator	Value	Signal
Rsi	53.59	NEUTRAL
Macd	5.9342	BEARISH
Ma Cross	391.71 / 360.77	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.53x	NORMAL

Key Levels

Level	Price
52-Week High	426.22
Bollinger Upper	421.07
SMA(200)	360.77
SMA(50)	391.71
SMA(20)	411.99
Current Price	409.38
Bollinger Lower	402.91
52-Week Low	282.77
ATR(14)	12.42

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence

100%

Acc: 0.0 | Dist: 0.0 | Markup: 2.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-08-31	Normal	1.03x	Normal bar — no special VSA pattern
2026-09-01	Normal	0.78x	Normal bar — no special VSA pattern
2026-09-02	Normal	0.94x	Normal bar — no special VSA pattern
2026-09-03	Normal	0.66x	Normal bar — no special VSA pattern
2026-09-04	Normal	0.53x	Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

Line	Value	Status
Tenkan-sen (9)	414.52	Above Kijun
Kijun-sen (26)	398.49	Base line
Senkou A	406.51	Leading span A
Senkou B	385.72	Leading span B
Cloud	385.72 – 406.51	Bullish (Green)
Price vs Cloud	409.38	Above Cloud
Chikou Span	377.31	Bullish
Alignment Score	4/4	BULLISH